With a revenue increase of 66.29% in the second quarter 2026, year on year to cumulative value of $770 million, Emergent Biosolutions Inc 's revenue per employee grew on a trailing twelve months basis to $ 855,778, this is below the company average.
Within the Healthcare sector Employees of 111 other companies have achieved higher revenue per employee. While Emergent Biosolutions Inc 's total ranking has deteriorated compared to the previous quarter from 351 to 1131. Emergent Biosolutions Inc has 900 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

EBS Revenue per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Revenue Change	66.29 %	-29.75 %	-23.63 %	-21.34 %	-44.68 %
Sales per Employee (TTM) $	855,778	752,000	825,444	876,556	946,222
EBS's Total Ranking	# 1131	# 351	# 1422	# 1592	# 1340
Seq. Revenue Change	50.1 %	4.98 %	-35.66 %	64.02 %	-36.59 %

EBS Company Profile >> Back to EBS Efficiency Comparisons >> Compare EBS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 77
Healthcare Sector	# 112
Overall Market	# 1131

Revenue per Employee Statistics
High	Average	Low
$ 2,002,667	$ 934,512	$ 305,197
(Dec 31 2021)		(Mar 31 2013)

Financial Statements
Emergent Biosolutions Inc 's Revenue MRQ	$ 234 Millions	Visit EBS's Income Statement
Emergent Biosolutions Inc 's Revenues TTM	$ 770 Millions	Visit EBS's aggregate revenue growth
What are EBS's Sales?		Visit EBS's Sales by Segment

Other Ratios
Emergent Biosolutions Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
EBS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for EBS's Competitors
Revenue per Employee for EBS's Suppliers
Revenue per Employee for EBS's Customers

You may also want to know
EBS's Sales Growth Rates	EBS's Pe Price to earnings ratio	EBS's Receivables Turnover Ratio	EBS's Stock Quote
EBS's Net Income Growth Rates	EBS's Ps Price to Sales ratio	EBS's Sales per Employee	EBS's Asset Turnover Ratio
EBS's Net Margin	EBS's Pb Price to Book ratio	EBS's Financial Strength Ratios	EBS's Dividend Payout Ratio

Date modified: 2026-09-08T01:14:04+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2026	Number of Employees Jun 30 2026
Arcutis Biotherapeutics Inc	1,310,680.79	$ 463.981 Million	354
Lantheus Holdings Inc	1,303,724.22	$ 1,555.343 Million	1,193
Cue Biopharma Inc	1,298,413.79	$ 37.654 Million	29
Puma Biotechnology Inc	1,291,865.92	$ 231.244 Million	179
Arvinas Inc	1,287,398.37	$ 316.700 Million	246
Travere Therapeutics Inc	1,189,798.79	$ 591.330 Million	497
Heron Therapeutics Inc	1,183,648.44	$ 151.507 Million	128
Journey Medical Corp	1,175,534.48	$ 68.181 Million	58
Theravance Biopharma inc	1,159,011.11	$ 104.311 Million	90
Corcept Therapeutics Inc	1,138,100.00	$ 830.813 Million	730
Akebia Therapeutics Inc	1,129,175.26	$ 219.060 Million	194
Siga Technologies Inc	1,095,079.92	$ 53.659 Million	49
Biomarin Pharmaceutical Inc	1,057,626.20	$ 3,406.614 Million	3,221
Hims and Hers Health Inc	1,055,894.35	$ 2,578.494 Million	2,442
Assembly Biosciences Inc	1,025,273.97	$ 74.845 Million	73
Sanara Medtech Inc	1,019,592.91	$ 110.116 Million	108
Ani Pharmaceuticals Inc	1,008,638.14	$ 978.379 Million	970
Coya Therapeutics Inc	1,002,393.13	$ 8.019 Million	8
Meiragtx Holdings Plc	986,354.84	$ 397.501 Million	403
Evolus Inc	949,440.12	$ 317.113 Million	334
Arrowhead Pharmaceuticals Inc	941,624.47	$ 669.495 Million	711
Scilex Holding Company	929,647.06	$ 31.608 Million	34
Ardelyx inc	922,073.62	$ 450.894 Million	489
The Oncology Institute Inc	916,137.29	$ 587.244 Million	641
Pacira Biosciences inc	900,077.20	$ 746.164 Million	829
Fortress Biotech Inc	897,217.95	$ 69.983 Million	78
Alphatec Holdings Inc	892,420.59	$ 814.780 Million	913
Merck and Co Inc	887,586.67	$ 66,569.000 Million	75,000
Nektar Therapeutics	866,492.06	$ 54.589 Million	63
Verastem Inc	858,098.04	$ 87.526 Million	102

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.